Ocular surface disease and vision-related quality of life in patients with glaucoma and ocular hypertension at Mettapracharak ( Wat Rai Khing) hospital

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20161009001

Enrollment

100

Registered

2016-10-09

Start date

2016-01-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

To study ocular surface disease (schirmer test&#44

Interventions

study prevalence of ocular surface disease and quality of life in glaucoma and ocular hypertension patients that visit glaucoma clinic at Mettapracharak( Wat Raikhing) hospital

Screening

glaucoma and ocular hypertension patients

Eligibility

Sex/Gender

All

Age

40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Glaucomatous or ocular hypertension patients 2. Age more than 40 years 3. Willing to participate and answer the questionnaire

Exclusion criteria

Exclusion criteria: 1. Secondary glaucoma 2. Not Willing to participate and answer the questionnaire

Design outcomes

Primary

Measure	Time frame
ocular surface diseases in glaucoma and ocular hypertension patients after received glaucoma medication schirmer test, tear break up time ,cornea and conjunctival staining	—

Secondary

Measure	Time frame
quality of life after received glaucoma medication EQ-5D-5L(Thai version,Ocular surface disease index : OSDI,VFQ-28 Thai version	—

Contacts

Public Contactvatookarn roongpoovapatr

Mettapracharak (Wat Rai Khing) hospital

drvatookarn@gmail.com034225832

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026

Ocular surface disease and vision&#45;related quality of life in patients with glaucoma and ocular hypertension at Mettapracharak ( Wat Rai Khing) hospital